ArticleTranslational psychiatry2025
Dissecting the heterogeneity of autism spectrum disorder with sensory behavior, brain, and epigenetic factors.
Article in Translational psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Movement-Anchored Emotional Memory: An Embodied Neuropsychological Framework.Journal of clinical medicine · 2026Review
- Organoid intelligence: a promising paradigm for autism spectrum disorder research.Molecular psychiatry · 2026Review
- Genome-Wide DNA Methylation Profiling of Peripheral Blood Mononuclear Cells Reveals Epigenetic Signatures in Autism Spectrum Disorder.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Autism spectrum disorder (ASD), a disorder with heterogeneous etiology, is characterized by abnormal behavioral responses to sensory inputs. However, there is still limited understanding of how brain and epigenetic factors, along with behavioral abnormality, contribute to ASD. After completing Adolescent-Adult Sensory Profile, a self-report questinnaire, 34 individuals with ASD and 72 controls underwent neuroimaging scans to measure brain structural (cortical and subcortical volume) and functional (thalamo-cortical resting-state functional connectivity) characteristics. For epigenetic measures, we computed DNA methylation values of the oxytocin receptor and arginine vasopressin receptor (AVPR) genes from the participants' saliva. When sensory-related behavior was the default baseline, a machine learning algorithm demonstrated that the neuroimaging-epigenetic model outperformed the neuroimaging model or the epigenetic model. Thalamo-cortical hyperconnectivity and AVPR 1A epigenetic modification were found to be significant contributing factors in these models. By integrating neuroimaging and epigenetic biomarkers with behaviors, a more precise diagnosis of ASD can be achieved.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.